Your browser doesn't support javascript.
loading
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population.
Wargny, Matthieu; Ducluzeau, Pierre-Henri; Petit, Jean-Michel; Le May, Cédric; Smati, Sarra; Arnaud, Lucie; Pichelin, Matthieu; Bouillet, Benjamin; Lannes, Adrien; Blanchet, Odile; Lefebvre, Philippe; Francque, Sven; Van Gaal, Luc; Staels, Bart; Vergès, Bruno; Boursier, Jérôme; Cariou, Bertrand.
Afiliação
  • Wargny M; L'institut du thorax, Department of Endocrinology, CIC 1413 INSERM, CHU Nantes, Nantes, France; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes, France.
  • Ducluzeau PH; Internal Medicine Department, Unit of Endocrinology, UMR85 INRA, CHU Tours, Tours, France.
  • Petit JM; University Bourgogne Franche-Comté, INSERM-LNC UMR 1231, Dijon, France; Department of Diabetes and Endocrinology, CHU François Mitterrand, Dijon, France.
  • Le May C; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes, France.
  • Smati S; L'institut du thorax, Department of Endocrinology, CIC 1413 INSERM, CHU Nantes, Nantes, France.
  • Arnaud L; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes, France.
  • Pichelin M; L'institut du thorax, Department of Endocrinology, CIC 1413 INSERM, CHU Nantes, Nantes, France; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes, France.
  • Bouillet B; University Bourgogne Franche-Comté, INSERM-LNC UMR 1231, Dijon, France; Department of Diabetes and Endocrinology, CHU François Mitterrand, Dijon, France.
  • Lannes A; Hepatology Department, Angers University Hospital, Angers, France.
  • Blanchet O; CRB - BB-0033-00038, Angers University Hospital, Angers, France.
  • Lefebvre P; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000, Lille, France.
  • Francque S; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine, University of Antwerp, Antwerp, Belgium.
  • Van Gaal L; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine, University of Antwerp, Antwerp, Belgium; Department of Endocrinology, Diabetology and Metabolism, University Hospital Antwerp, Edegem, Belgium.
  • Staels B; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000, Lille, France.
  • Vergès B; University Bourgogne Franche-Comté, INSERM-LNC UMR 1231, Dijon, France; Department of Diabetes and Endocrinology, CHU François Mitterrand, Dijon, France.
  • Boursier J; Hepatology Department, Angers University Hospital, Angers, France; HIFIH Laboratory, UPRES 3859, SFR 4208, Bretagne Loire University, Angers, France.
  • Cariou B; L'institut du thorax, Department of Endocrinology, CIC 1413 INSERM, CHU Nantes, Nantes, France; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes, France. Electronic address: bertrand.cariou@univ-nantes.fr.
Atherosclerosis ; 278: 82-90, 2018 11.
Article em En | MEDLINE | ID: mdl-30261472

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fígado Gorduroso / Hepatopatia Gordurosa não Alcoólica / Pró-Proteína Convertase 9 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fígado Gorduroso / Hepatopatia Gordurosa não Alcoólica / Pró-Proteína Convertase 9 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2018 Tipo de documento: Article